Clinical Trial Update: REVErsing Airway Remodelling With Tezepelumab [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tezepelumab for reversing airway remodeling in asthmatic patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Remodeling
• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Airway Remodelling, Asthmatic | Phase 3 | Status: RECRUITING